Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00261378
What this trial is testing

Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation

Who this might be right for
Primary Liver Cancer
Boston Scientific Corporation 212
Not applicableStudy completedNCT02475889
What this trial is testing

Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer

Who this might be right for
Colorectal Cancer
The First People's Hospital of Changzhou 78
Testing effectiveness (Phase 2)UnknownNCT00247260
What this trial is testing

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
pSiVida Limited 50
Not applicableUnknownNCT02644603
What this trial is testing

Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 214
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05545124
What this trial is testing

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Who this might be right for
Hepatocellular Carcinoma
Henan Cancer Hospital 32
Testing effectiveness (Phase 2)Study completedNCT00128596
What this trial is testing

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
University of Pittsburgh 25
Not applicableUnknownNCT05473325
What this trial is testing

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

Who this might be right for
DiabetesChronic Kidney DiseasesCancer+25 more
Willows Health 2,000
Testing effectiveness (Phase 2)Study completedNCT00052364
What this trial is testing

Oxaliplatin in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)WithdrawnNCT00093548
What this trial is testing

Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT06261047
What this trial is testing

Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer

Who this might be right for
Hepatocellular CarcinomaRadiotherapy
Shandong Cancer Hospital and Institute 36
Early research (Phase 1)Ended earlyNCT02893982
What this trial is testing

High Dose Rate Brachyablation of Primary Liver Lesions

Who this might be right for
Liver Cancer
University of Texas Southwestern Medical Center 1
Early research (Phase 1)Study completedNCT00030082
What this trial is testing

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00012324
What this trial is testing

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

Who this might be right for
Liver Cancer
Eximias Pharmaceutical
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Not applicableStudy completedNCT04269499
What this trial is testing

Real-time Imaging of Holmium Radioembolization: a Feasibility Study

Who this might be right for
Liver CancerLiver Metastases
Radboud University Medical Center 6
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Post-approval studies (Phase 4)WithdrawnNCT02853500
What this trial is testing

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Who this might be right for
Liver Cancer
Dana-Farber Cancer Institute
Not applicableStudy completedNCT00132041
What this trial is testing

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
American College of Radiology Imaging Network 51
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Next Page